メニュー
Meet the Program Commitee for 2024!
プログラム委員会
-
Venkatraman Balasubramanian, PhD, MBA • Healthcare and Life Sciences Strategic Advisor
VB Insights, LLC, United States -
Greg Ball, PhD • Safety Data Scientist
ASAPprocess, United States -
Sanghita Bhattacharya, PhD • Director Data Science Global Function
Johnson & Johnson Innovative Medicine, United States -
Claire Blanchette, PMP • Executive Drug Development Program Leader
Consultant, United States -
Tywnia Brewton • Executive Director, Human Resources
Astellas , United States -
Susan Callery-D'Amico, BSN • Retired, Vice President, R&D Quality Assurance, AbbVie
United States -
Brooke Casselberry, MS, RAC • Vice President, Advisory and Delivery
Epista Life Sciences, United States -
Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
FDA, United States -
Wendy Charles, PhD • Chief Ethics and Compliance Officer; Adjunct Faculty
Equideum Health, United States -
Ethan Chen, MBA, MS, PMP • Director, Division of Data Management
FDA CDER, United States -
Mary Ellen Cosenza, PhD, MS, RAC • President
MEC Regulatory & Toxicology Consulting, LLC, United States -
Stephanie Y. Crawford, PhD, MPH, MS • Professor, Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago, United States -
Alysha Croker, PhD • Director of the Centre for Policy, Pediatrics and International Collaboration
Health Canada, Canada -
Ebony Dashiell-Aje, PhD • Executive Director and Head, Patient Centered Outcomes Science
BioMarin, United States -
Megan Doyle, JD, MPH • Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly & Company, United States -
Nancy A Dreyer, PhD, MPH, FISPE • Founder
Dreyer Strategies LLC, United States -
Jennifer Emerson, PhD, MPH, RN, PMP • Head Quality Analytics & Risk Management
Boehringer Ingelheim, Germany -
Andrew Emmett, MPH • FDA Liaison | US Regulatory Policy and Global Intelligence
Pfizer Inc, United States -
Ron Fitzmartin, PhD, MBA • Senior Advisor, Office of Regulatory Operations, CBER
FDA, United States -
Celeste Frankenfeld Lamm • Senior Director, Global Regulatory Affairs – CMC
Merck Sharp & Dohme LLC , United States -
Danielle Friend Economo, PhD • Senior Director, US Head Regulatory Policy and Intelligence
Johnson & Johnson Innovative Medicine, United States -
David Fryrear, MS • Executive Vice President and Head of Quality Assurance
Astellas, United States -
Alicia Gilsenan, PhD, MS, RPh, FISPE • Vice President, Epidemiology
RTI Health Solutions, United States -
Cheryl Grandinetti, PharmD • Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
FDA, United States -
Renmeet Grewal, PharmD, MS • Division Director, Office of Regulatory Operations (DRO-II), OND, CDER
FDA, United States -
Lani Hashimoto • Consultant, Patient Engagement
Hashimoto Consulting Services, United States -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Cammilla Horta Gomes, MA, MPharm • Latam Regulatory Policy Lead
Roche, Brazil -
Stacy Hurt, MBA, MHA • Chief Patient Officer
Parexel , United States -
Emily (Xianghong) Jing, PhD • Associate Director for Scientific Coordination, OBP, OPQ, CDER
FDA, United States -
Jeremy Jokinen, PhD, MS • Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States -
Mark Kryah, PMP • Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States -
Dominique Lagrave, PharmD • Senior Vice President of Regulatory Innovation
Accumulus Synergy, United States -
Cathryn C Lee, MSN • Director, Office of Program Operations, PDIMS, OND, CDER
FDA, United States -
Jingyu (Julia) Luan, PhD • Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States -
Demetra Macheras, MBA • Director, Regulatory Policy and Intelligence - Regulatory Affairs
AbbVie, United States -
Nicole Mahoney, PhD • Executive Director US Regulatory Policy & Intelligence
Novartis Pharmaceuticals Corporation, United States -
Lindsay McNair, MD, MPH, MS • Principal Consultant
Equipoise Consulting, United States -
Melodi J McNeil, MS, RPh • Director, Regulatory Policy and Intelligence
AbbVie, United States -
David Meats • Director, Regulatory Services Management
Certara, United States -
Munish Mehra, PhD, MS, MSc • Managing Director and Sr. Principal Biostatistician
Quantum Biopharma, United States -
Timothe Menard, PharmD, MSc • Global Head, Quality Excellence Digital | Bioethics Coach (Data Ethics)
F. Hoffmann-La Roche Ltd, Switzerland -
Alexis Miller, JD • Acting Global Lead, Global Regulatory Policy and Intelligence
Merck & Co., Inc., United States -
Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
FDA, United States -
Martha Monser • Consumer Safety Officer, Office of Regulatory Operations, CBER
FDA, United States -
Monica Munoz, PharmD, PhD • Division Director, Division of Pharmacovigilance-I, OSE, CDER
FDA, United States -
Ana Padua, MSc, RPh • Director EU Global Regulatory and Scientific Policy
EMD Serono (Merck Group), Switzerland -
Kim Ribeiro, MS • Chief Client Officer
Inside Edge Consulting Group, United States -
Margaret Richards, PhD, MPH • Executive Director, Solutions
Panalgo, United States -
Cynthia Rothblum-Oviatt • Science Policy Analyst, Rare Disease Team, OND, CDER
FDA, United States -
Leslie Sam • President
Leslie Sam and Associates, LLC, United States -
Earl Seltzer, MBA • Senior Director, Partnerships and Innovation
CTI, United States -
Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
Bristol-Myers Squibb Company, United States -
Elizabeth Somers, MS • Executive Director, Global Project and Alliance Management
Merck Sharp & Dohme LLC, United States -
Nancy Linda Styple • Project Management Leader
Bayer AG, United States -
Ling Su, PhD • Research Fellow
Shenyang Pharmaceutical University, Yeehong Business School, China -
Linda B Sullivan, MBA • Senior Fellow
Tufts Center For the Study of Drug Development, United States -
Alec Thompson, PharmD, MS • Senior Product Manager, Oncology
Gilead Sciences, United States -
Phil Tregunno • Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Rachel Turow, JD, MPH • Managing Counsel, FDA Regulatory
Walmart, Inc., United States -
Yoshiaki Uyama, PhD, MS, RPh • Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Pujita Vaidya, MPH • North America Lead, Regulatory Science and Policy
Sanofi, United States -
James Valentine, JD, MHS • Director
Hyman, Phelps & McNamara, PC, United States -
James Wabby, MHS • Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States -
Paula Walker, MA • Global Head of Risk Based Quality Management
Roche Products Ltd., United Kingdom -
Susan Wang, PhD • Global Head of Biostatistics and Data Sciences Inflammation
Boehringer Ingelheim, United States -
Robin Whitsell • President
Whitsell Innovations, Inc., United States -
Representative Invited • DIA, United States